Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3165-3170
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3165
Figure 1
Figure 1 Intestinal lesions induced by meloxicam. A: Normal control rats; B: AA rats; C: AA rats given meloxicam intragastrically; D: AA rats treated with oral CII; E: AA rats treated with nasal CII; F: AA + meloxicam rats treated with oral CII; and G: AA + meloxicam rats treated with nasal CII.
Figure 2
Figure 2 Effects of oral or nasal administration of CII on knee joint histopathology in AA rats with or without intragastrical administration of meloxicam (HE stain, × 100). A: Normal control rats (grade 0); B: AA rats (grade 4); C: AA rats given meloxicam intragastrically (grade 4); D: AA rats treated with oral CII (grade 3); E: AA rats treated with nasal CII (grade 2); F: AA + meloxicam rats treated with oral CII (grade 3); and G: AA + meloxicam rats treated with nasal CII (grade 2).